American Society for Transplantation and Cellular Therapy (ASTCT)

LentiGlobin gene therapy for transfusion-dependent β-thalassemia: outcomes from the phase 1/2 Northstar and phase 3 Northstar-2 studies.

Authors: Anurtathapan U.